FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
134 hedge funds and large institutions have $823M invested in Flexion Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 40 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
23
Increased
39
Reduced
40
Closed
27
Calls
$9.66M
Puts
$4.06M
Net Calls
+$5.6M
Net Calls Change
+$6.81M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$23.6M |
| 2 |
Millennium Management
New York
|
+$15.5M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$4.65M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.52M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.96M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$5.85M |
| 2 |
ACM
Advent Capital Management
New York
|
-$3.9M |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
-$3.29M |
| 4 |
Bank of New York Mellon
New York
|
-$2.75M |
| 5 |
BPIM
Brant Point Investment Management
New York
|
-$2.63M |
